|
|
Volumn 22, Issue 2, 2015, Pages 64-66
|
|
Moving from tinkering in the garage to assembly line production: The manufacture of genetically modified T cells expressing chimeric antigen receptors (CARs) comes on line
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CHIMERIC ANTIGEN RECEPTOR;
T LYMPHOCYTE RECEPTOR;
TUMOR ANTIGEN;
LYMPHOCYTE ANTIGEN RECEPTOR;
ADOPTIVE IMMUNOTHERAPY;
ANTIGEN SPECIFICITY;
GENETICALLY MODIFIED T CELL;
GOOD MANUFACTURING PRACTICE;
HUMAN;
IMMUNOLOGICAL TOLERANCE;
PRIORITY JOURNAL;
REVIEW;
T LYMPHOCYTE;
TUMOR MICROENVIRONMENT;
CELL LINEAGE;
GENE EXPRESSION REGULATION;
GENETIC ENGINEERING;
GENETICS;
IMMUNOLOGY;
NEOPLASMS;
ANTIGENS, NEOPLASM;
CELL LINEAGE;
GENE EXPRESSION REGULATION, NEOPLASTIC;
GENETIC ENGINEERING;
HUMANS;
IMMUNOTHERAPY, ADOPTIVE;
NEOPLASMS;
RECEPTORS, ANTIGEN, T-CELL;
T-LYMPHOCYTES;
|
|
EID: 84924662607
PISSN: 09291903
EISSN: 14765500
Source Type: Journal
DOI: 10.1038/cgt.2014.70 Document Type: Review |
|
Times cited : (8)
|
|
References (0)
|
